Curcumin, Berberine, and Quercetin: Evidence Review for Enhancing Fenbendazole's Effects (2025 Update)
In the realm of integrative oncology, few natural compounds hold as much promise for amplifying repurposed therapies like fenbendazole as curcumin , berberine , and quercetin . These plant-derived powerhouses—staples in the updated Joe Tippens Protocol—aren't just buzzwords; they're backed by a surge of 2023-2025 research showing synergistic effects that could enhance fenbendazole's microtubule disruption and metabolic targeting in cancers like breast, prostate, and lung. As preclinical trials and case series mount (over 380 self-reported remissions by mid-2025) , this trio emerges as a low-cost, accessible booster for those navigating advanced disease. But evidence varies—strong for curcumin's synergies, emerging for the others—and always pair with professional oversight. At OneDayMD, we sift the science to empower you: let's explore the mechanisms, data, and real-world application. Fenbendazole's Core Action: A Primer for Synergy Fenbendazole (FBZ), the benzi...